Skip to main content

EVR 25 Pill - white round, 6mm

Pill with imprint EVR 25 is White, Round and has been identified as Everolimus 0.25 mg. It is supplied by Ascend Laboratories LLC.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Renal Angiomyolipoma; Pancreatic Cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EVR 25

Everolimus 0.25 mg EVR 25

Everolimus

Imprint
EVR 25
Strength
0.25 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ascend Laboratories LLC
Manufacturer
Alkem Laboratories Limited
National Drug Code (NDC)
67877-0718
Inactive Ingredients
butylated hydroxytoluene, lactose monohydrate, hypromelloses, lactose anhydrous, crospovidone, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "EVR 25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.